Nanjing Medical To Build Health Care Industrial Park
This article was originally published in PharmAsia News
Nanjing Medical Company has signed a 20-year real estate and land lease with Nanjing Compressor Co., Ltd. According to the contract, Nanjing Compressor will lease its number one production zone including all buildings, auxiliary equipment, facilities, fittings and land to Nanjing Medical at a total of 229.19 million yuan for the next 20 years. Nanjing Medical is to put in 5.5 million yuan for 55 percent equity of a new management company, which will be set up to oversee construction of the industrial park. With its focus on integrating logistics resources, Nanjing Medical is looking for investors to develop the municipal park into a center for high-end preventive medicine, health care and rehabilitation, business, product R&D and modern logistics. (Click here for more - Chinese Language)
You may also be interested in...
The European Commission has unexpectedly concluded that CBD should not be considered as drug opening up the path to regulated EU market for the cannabinoid as a novel food.
As Apotex names its new US president and CEO, Akorn puts together a fresh board of directors following bankruptcy proceedings. Stada has made new appointments in Germany, while Siegfried makes significant changes in its leadership roles.
A WHO recommendation to explicitly exempt low-THC CBD from international narcotics controls has been emphatically rejected by UN member states. The CBD industry had hoped for a positive outcome to remove regulatory pressure on product manufacturers in Europe and around the world.